CVS Health Corp
Latest CVS Health Corp News and Updates
Stocks & Markets Small Window Open for Signify Stock Before CVS Acquisition
Signify Health stock is trending upwards amid news of an official acquisition by major drugstore chain CVS Health. Is it a buy or should you hold out?Investments & Deals CVS Wants to Acquire Signify—The Potential Deal, Explained
CVS reportedly has plans to put in a bid to acquire Signify Health. What are the expected terms of the deal, and will it go through?Healthcare Walmart and CVS Will Stop Filling Certain Controlled Substance Prescriptions
CVS and Walmart have decided to longer fill prescriptions for controlled substances issued by Cerebral and Done. We'll see why and what it means for some customers.Stocks & Markets CVS Is Closing Some Stores Amid Market and Industry Changes
Some CVS stores are closing across the U.S. and customers are being directed to alternative outlets. What stores are closing and why is the company making changes?News CVS Will Close 900 Stores Starting in 2022—Closures Will Span 3 Years
On Nov. 18, CVS announced that it will be closing 900 stores across the U.S. Why will there be store closures?Company & Industry Overviews S&P 500’s Top Losses: Why Biogen Declined
Biogen, which is an American multinational biotechnology company, was the S&P 500’s top loss on June 18.Miscellaneous Could the Rite Aid–Walgreens Merger Get Competitive?
In the Rite Aid–Walgreens merger, Walgreens is paying about 0.6x trailing-12-month revenues and 13.6x trailing-12-month EBITDA.Company & Industry Overviews CVS versus Walgreens: Which Has a More Diversified Business Model?
CVS generates close to 70% of its annual sales by offering a full range of pharmacy benefit management services.Earnings Report How Is UNH’s Optum Business Positioned in the Industry?
UnitedHealth Group is, by revenue, the largest healthcare company in the world.Company & Industry Overviews Costco’s Industry Positioning: A Porter’s 5 Force Analysis
Costco’s suppliers include companies like PepsiCo (PEP), Procter & Gamble (PG), and the Kraft Heinz Company (KHC). No single supplier accounts for over 5% of revenue.Earnings Report Will Walgreens’ Q3 Results Beat Wall Street’s Forecast?
Unlike several other US companies, Walgreens didn’t suspend its dividends due to COVID-19. As of July 6, the company’s dividend yield was 4.2%.Consumer Walmart to Boost Pharmacy Business with CareZone’s Tech Acquisition
Today, CNBC reported that Walmart (NYSE:WMT) has acquired prescription management technology from CareZone to boost its pharmacy space.Consumer CVS Health Stock: What’s Fueling Growth and Will the Uptrend Last?
CVS Health stock is up about 13% in November. Strong financial performance is driving the stock higher, but low earnings growth could limit further upside.Consumer Analyzing Target’s Same-Store Sales Growth in Fiscal 2016
Target had upbeat revenue performance in fiscal 4Q16 and 2016. Store traffic was up by 1.3% YoY in fiscal 2016, trending in positive territory in all four quarters of the year.Company & Industry Overviews Why Target Is Focusing on Its Signature Categories to Drive Sales
Target has identified four signature categories it’s concentrating on to provide higher store and web traffic and sales: Baby, Style, Wellness, and Kids.Company & Industry Overviews Merchandise Mix: Which Categories Are Performing Best at Target?
In fiscal 2016, Target’s (TGT) performance was upbeat for all merchandise categories with the exception of hardlines.Consumer Charlotte’s Web Holdings Stock Down after Earnings
Charlotte’s Web Holdings stock (CWBHF)(CWEB) was down 6.6% yesterday after the company reported lower-than-expected Q2 earning results.Consumer Walgreens or CVS Stock: Which Is a Better Value Buy?
Walgreens and CVS Health shares are trading at a low valuation multiple. The stocks have fallen 22.3% and 8.7%, respectively, in 2019.Company & Industry Overviews Walgreens Will Close 200 US Stores
In a regulatory filing on Tuesday, Walgreens Boots Alliance (WBA) announced that it will close 200 stores in the US to focus on store optimization.Consumer What’s Hurting CVS and Walgreens Stocks?
Walgreens Boots Alliance stock (WBA) fell 6.4% on March 1 after Baird’s reduction in target price.Consumer What’s the Dividend Yield of the Consumer Non-Cyclical Sector?
The consumer non-cyclical segment recorded a dividend yield of 3%.Company & Industry Overviews CVS Health and Walgreens: Financial Health
CVS recorded total sales of $186 billion (+4% YoY) in the last 12 months. The Pharmacy Services segment was the company’s biggest moneymaker.Company & Industry Overviews CVS Health versus Walgreens: Comparing Pharmacy Giants
Around 70% of the US population lives within three miles of a CVS store, while more than 75% of the population lives within five miles of a Walgreens store.Company & Industry Overviews What’s LHC Group’s Business Strategy?
In 2018, LHC Group is expected to report revenue of $1.2 billion. What about its peers?Consumer How the Drug Store Industry Is Changing
The top three drugstore chains in the US are in the process of forming new associations through mergers and acquisitions to create a more diversified portfolio and protect themselves from the growing online threat.Company & Industry Overviews Consumer Sector Insights for the First Week of 2018
The consumer staples sector had a slight gain of 0.10% led by a stock increase in the stock price of CVS Health, Coty, Estee Lauder, and Walmart.Healthcare A Look at the Financial Details of the CVS-Aetna Deal
CVS is paying more than 11 times the trailing 12-month EBITDA for Aetna.Company & Industry Overviews Walgreens versus CVS: Discussing PBM Strategies
In August 2016, Walgreens announced a long-term strategic alliance with Prime Therapeutics, America’s fourth-largest PBM.Company & Industry Overviews Walgreens versus CVS: Comparing International Presence
The US is Walgreens’ largest market and accounts for more than 70% of its total sales and operating income.Company & Industry Overviews Walgreens versus CVS: Comparing Pharmacy Giants
The US drugstore market is dominated by two major players—CVS Health (CVS) and Walgreens Boots Alliance (WBA). CVS and WBA accounted for ~29% of the country’s prescription dispensing revenues in 2016.Consumer A Look at Rite Aid’s Stock Crash This Year
Rite Aid’s shareholders have been the real losers from the delay and eventual termination of the deal between Rite Aid (RAD) and Walgreens Boots Alliance (WBA) in October 2015.Consumer Here’s Why Rite Aid’s Margins Have Deteriorated over the Years
Rite Aid’s profitability has worsened over the years. Its gross margin has fallen from 29.0% in fiscal 2013 to just 22.6% in the first quarter of the current fiscal year.Consumer Kao Corporation: What’s Sharpening Its Competitive Edge?
Kao Corporation has become the largest branded and packaged goods company in Japan and the second-largest company in the cosmetics category.Real Insights How to Identify Economic Moats
In this series, we’ll discuss how intangible assets can create long-term competitive advantages for companies.Company & Industry Overviews Eosinophilic Esophagitis: Major Market Opportunity for Dupixent?
Regeneron (REGN) has obtained positive results from its Phase 2 proof-of-concept study evaluating Dupixent in eosinophilic esophagitis.Earnings Report Looking Back: What Drove Target’s Top Line in 2Q16?
In 2Q16, mass merchandiser Target (TGT) reported a 7.2% decline in its top line to $16.2 billion. Target’s 2Q16 revenues were affected by lower traffic and higher variability in sales patterns.Company & Industry Overviews Upcoming Opportunities and Potential Threats for Walgreens Boots
In this part, we’ll discuss the company’s upcoming opportunities and potential threats.Company & Industry Overviews An Analysis of Walgreens Boots Alliance’s Stock Returns
Walgreen Boots Alliance’s (WBA) common stock trades on the NASDAQ under the symbol “WBA.”Company & Industry Overviews Comparing the Pharmacy Giants: Walgreens versus CVS Health
Walgreens Boots Alliance (WBA) and CVS Health (CVS) largely dominate the US drug store market.Company & Industry Overviews Porter’s Five Forces Analysis of the US Drugstore Industry
Porter’s five forces model is used to assess the nature of competition and attractiveness of an industry.Company & Industry Overviews An Overview of the US Drugstore Industry
US drugstores typically generate revenues by selling prescription drugs, over-the-counter medications, health and beauty products, and general merchandise.Company & Industry Overviews A Look at Walgreens Boots Alliance’s Retail Pharmacy USA Division
The Retail Pharmacy USA division is Walgreens Boots Alliance’s (WBA) largest revenue generator.Company & Industry Overviews Walgreens Boots Alliance: Segments and Geographic Footprint
Following the completion of the second-step transaction on December 31, 2014, Walgreens Boots Alliance reorganized its operations into three segments.Earnings Report CVS’ Retail Pharmacy Market Share Rises in 2Q15 on Scripts Growth
CVS Health’s Retail Pharmacy segment reported sales of $17.2 billion in 2Q15, an increase of 2.2% over 2Q14. CVS boosted its share of the retail pharmacy market to 21.6% in 1Q15, from 21% in 2Q14.Earnings Report Major Factors Driving CVS’s Retail Pharmacy Segment Growth
CVS Health (CVS) expects Retail Pharmacy sales growth between 0.5% and 2% year-over-year in 2Q15. Total same-store sales are expected to be in the range of -1.25% to 0.25%.Macroeconomic Analysis Leading Indicators that Help Identify the Current Business Cycle
The business cycle, which reflects fluctuations of activity in an economy, can be a critical determinant of equity sector performance over the intermediate term.Fund Managers Blue Ridge Capital Opens New Position in Walgreens Boots Alliance
Walgreens Boots Alliance is a firm created by the merger of Walgreens and Alliance Boots in December 2014.